Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Researchers find increased activity in visual, auditory and sensorimotor network in migraineurs

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Medical Device Innovation and Regulatory Strategy...

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Medtronic Wins FDA Clearance for MiniMed...

Medtronic has received U.S. Food and Drug Administration (FDA)...

Typically, migraine is considered to be an episodic disorder with discrete attacks of headache. But new research by Dr. Till Sprenger and his team from UCSF Headache Group and Technische Universit-t M-nchen found increased network activity — stronger functional connectivity — bilaterally in the visual, auditory and sensorimotor network in migraineurs.

"There has been increasing evidence that the processing and perception of sensory stimuli is abnormal even outside of attacks," said Dr. Sprenger. "Now our findings underline that abnormal brain activity in migraineurs is not restricted to attacks – that there is an extensive alteration of functional connectivity in multiple networks reflecting the migrainous phenotype, emphasizing that migraine is a disorder of the brain."

Findings will be presented at the American Headache Society’s 52nd Annual Scientific Meeting in Los Angeles this week.

"This research has been anticipated for some time and is absolutely fundamental to our understanding of migraine," said David Dodick, M.D. president of the American Headache Society. "It is likely that the observed interictal abnormalities of brain activity and connectivity explains the predisposition to spontaneous attacks, as well as the vulnerability of migraineurs to a myriad of external and endogenous triggers. It may also explain the persistence of headache in some sufferers and the persistence of symptoms in between attacks of pain (e.g. sensitivity to light)."

More than 200 scientific papers and posters are being presented during the AHS meeting which is expected to draw some 500 migraine and headache health professionals including doctors, researchers, and specialists.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Medical Device Innovation and Regulatory Strategy Trends

A comprehensive look at how the medical device sector is navigating the complex intersection of cutting-edge technology and increasingly stringent global regulations. The industry is currently shifting toward a more data-centric approach to compliance, where clinical validation and quality assurance are integrated into the earliest stages of product development.

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Utilizing Real-World Evidence to Improve Trial Outcomes

Real-world evidence represents clinical data collected outside traditional controlled trial environments, derived from sources including electronic health records, insurance claims databases, disease registries, wearable devices, and patient-reported outcomes.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »